What's Happening East of 101? A Biotech & Beyond Speaker Series ft. Abbvie

About Abbvie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. Founded in 2013 as a spin-off from Abbott, AbbVie became a dedicated science-focused biopharmaceutical company that now operates globally with close to 57,000 employees working cross science, research and manufacturing. Its work is driven by a patient-centered approach, emphasizing treatments that are safe, effective and accessible. AbbVie’s products and services reach tens of millions of people each year across more than 175 countries, reflecting its broad global impact.

About Chris Tse

Chris serves as site head for AbbVie’s Bay Area site where he develops and implements strategies that maximize access to technology, innovation and top talent from across the Bay Area. He is also responsible for setting the strategic vision for AbbVie’s Obesity Discovery program—building a small expert team that will pave the way for future expansion. In addition, he leads the Venture Partners group. In partnership with AbbVie Ventures, his work will strengthen relationships and engagements with next-generation innovators. Chris joined AbbVie in 2004 and has since held multiple leadership roles that spanned across our five therapeutic areas.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher City of South San Francisco